{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:17:21Z","timestamp":1768897041847,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.canrad.2016.08.130","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T22:16:27Z","timestamp":1486592187000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ototoxicit\u00e9 radio-induite et chimio-induite dans les cancers ORL\u00a0: de la pr\u00e9vention primaire \u00e0 la pr\u00e9vention tertiaire"],"prefix":"10.1016","volume":"21","author":[{"given":"S.","family":"Espenel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-B.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ben Mrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Langrand-Escure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"El Meddeb Hamrouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Trone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rancoule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2016.08.130_bib0265","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","article-title":"Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment","volume":"91","author":"Marur","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.canrad.2016.08.130_bib0270","series-title":"Les cancers en France, les donn\u00e9es, INCa, janvier 2014","author":"Anon","year":"2015"},{"key":"10.1016\/j.canrad.2016.08.130_bib0275","first-page":"118","article-title":"Cancers with increasing incidence trends in the United States: 1999\u00a0through 2008","volume":"62","author":"Simard","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2016.08.130_bib0280","first-page":"401","article-title":"Oral cavity and oropharyngeal squamous cell carcinoma\u00a0\u2013\u00a0an update","volume":"65","author":"Chi","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.canrad.2016.08.130_bib0285","doi-asserted-by":"crossref","first-page":"v184","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Gr\u00e9goire","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0290","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2016.08.130_bib0295","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canrad.2010.02.011","article-title":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: l\u2019oreille","volume":"14","author":"Fleury","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.08.130_bib0300","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hed.23201","article-title":"Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review","volume":"35","author":"Mujica-Mota","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2016.08.130_bib0305","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hed.23551","article-title":"Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature","volume":"37","author":"Theunissen","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2016.08.130_bib0310","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijrobp.2006.09.017","article-title":"Ototoxicity after radiotherapy for head and neck tumors","volume":"67","author":"Bhandare","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0315","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hed.20426","article-title":"Permanent unilateral hearing loss after radiotherapy for parotid gland tumors","volume":"28","author":"van der Putten","year":"2006","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2016.08.130_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(02)00211-6","article-title":"Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature","volume":"65","author":"Raaijmakers","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0325","first-page":"365","article-title":"A review of cis-platinum ototoxicity","volume":"12","author":"Moroso","year":"1983","journal-title":"J Otolaryngol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0330","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0335","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1748-717X-7-215","article-title":"The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity","volume":"7","author":"Tsan","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0305-7372(03)00066-5","article-title":"Radiotherapy-induced ear toxicity","volume":"29","author":"Jereczek-Fossa","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canrad.2016.08.130_bib0345","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0360-3016(03)00413-9","article-title":"Radiation tolerance of normal temporal bone structures: implications for gamma knife stereotactic radiosurgery","volume":"57","author":"Linskey","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0350","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0360-3016(91)90692-W","article-title":"Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma","volume":"21","author":"Grau","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0355","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0194-5998(98)70276-1","article-title":"Histopathology of human temporal bone after cis-platinum, radiation, or both","volume":"118","author":"Hoistad","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2016.08.130_bib0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40463-014-0030-x","article-title":"Cochlea sparing effects of intensity modulated radiation therapy in head and neck cancers patients: a long-term follow-up study","volume":"43","author":"Theunissen","year":"2014","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2016.08.130_bib0365","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.ijrobp.2004.08.019","article-title":"Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients","volume":"61","author":"Pan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0370","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2008.08.011","article-title":"Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors","volume":"74","author":"Zuur","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0375","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrclinonc.2011.106","article-title":"Organ-sparing radiation therapy for head and neck cancer","volume":"8","author":"Wang","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0380","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0773.1995.tb00167.x","article-title":"Mechanism of cisplatin ototoxicity: antioxidant system","volume":"76","author":"Ravi","year":"1995","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0385","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0390","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1002\/lary.24360","article-title":"Cisplatin otoprotection using transtympanic l-N-acetylcysteine: a pilot randomized study in head and neck cancer patients","volume":"124","author":"Yoo","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2016.08.130_bib0395","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1288\/00005537-198312000-00007","article-title":"Cis-platinum ototoxicity: clinical experience and temporal bone histopathology","volume":"93","author":"Strauss","year":"1983","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2016.08.130_bib0400","first-page":"559","article-title":"Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells","volume":"18","author":"Kopke","year":"1997","journal-title":"Am J Otol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0405","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ijrobp.2008.05.040","article-title":"Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients","volume":"73","author":"Hitchcock","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0410","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(00)02044-4","article-title":"Circulating plasma platinum more than 10\u00a0years after cisplatin treatment for testicular cancer","volume":"355","author":"Gietema","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2016.08.130_bib0415","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0277-5379(83)90398-X","article-title":"Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration","volume":"19","author":"Vermorken","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0420","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000095818","article-title":"Audiometric patterns in ototoxicity of intra-arterial cisplatin chemoradiation in patients with locally advanced head and neck cancer","volume":"11","author":"Zuur","year":"2006","journal-title":"Audiol Neurootol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0425","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/000348949910801211","article-title":"Radiation-induced hearing impairment in patients treated for malignant parotid tumor","volume":"108","author":"Chen","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0430","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.21683","article-title":"Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma","volume":"106","author":"Chen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.08.130_bib0435","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.07.034","article-title":"Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis","volume":"73","author":"Chan","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0440","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ijrobp.2007.03.027","article-title":"Ototoxicity after radiotherapy of head-and-neck cancer: the perils of retrospective dose-response estimations: in regard to Bhandare et al. (Int J Radiat Oncol Biol Phys 2007;67:469\u201379)","volume":"68","author":"Pan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0445","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0450","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0360-3016(03)00570-4","article-title":"Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma","volume":"57","author":"Emami","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0455","doi-asserted-by":"crossref","first-page":"121724","DOI":"10.1118\/1.4830427","article-title":"Measuring uncertainty in dose delivered to the cochlea due to setup error during external beam treatment of patients with cancer of the head and neck","volume":"40","author":"Yan","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2016.08.130_bib0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2015.12.029","article-title":"Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer\u00a0\u2013\u00a0Comparison of dose, toxicity and cost-effectiveness","author":"Cheng","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0465","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01\u00a0French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0470","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93\u00a0randomised trials and 17,346\u00a0patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0475","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2016.08.130_bib0480","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3\u00a0randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0485","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1023\/A:1008353505916","article-title":"Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group","volume":"10","author":"Planting","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0490","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/lary.24802","article-title":"Long-term hearing loss after chemoradiation in patients with head and neck cancer","volume":"124","author":"Theunissen","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2016.08.130_bib0495","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0003489414534010","article-title":"A new grading system for ototoxicity in adults","volume":"123","author":"Theunissen","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0500","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/000348948809700210","article-title":"Prospective study of the effects of ventilation tubes on hearing after radiotherapy for carcinoma of nasopharynx","volume":"97","author":"Chowdhury","year":"1988","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0505","first-page":"828","article-title":"Extended high-frequency ototoxicity induced by the first administration of cisplatin","volume":"122","author":"Sakamoto","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2016.08.130_bib0510","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.3342\/ceo.2012.5.S1.S93","article-title":"Cochlear implant outcomes: a comparison between irradiated and non-irradiated ears","volume":"5","author":"Soh","year":"2012","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.canrad.2016.08.130_bib0515","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/01.mlg.0000225935.80559.11","article-title":"Cochlear implantation in post-irradiated ears: outcomes and challenges","volume":"116","author":"Low","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2016.08.130_bib0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mhn.2002.121915","article-title":"Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness?","volume":"126","author":"Aslan","year":"2002","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:26:44Z","timestamp":1761136004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321817300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1278321817300033"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.08.130","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ototoxicit\u00e9 radio-induite et chimio-induite dans les cancers ORL\u00a0: de la pr\u00e9vention primaire \u00e0 la pr\u00e9vention tertiaire","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.08.130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}